GB202102556D0 - Method for reducing antibiotic resistance emergence - Google Patents

Method for reducing antibiotic resistance emergence

Info

Publication number
GB202102556D0
GB202102556D0 GBGB2102556.4A GB202102556A GB202102556D0 GB 202102556 D0 GB202102556 D0 GB 202102556D0 GB 202102556 A GB202102556 A GB 202102556A GB 202102556 D0 GB202102556 D0 GB 202102556D0
Authority
GB
United Kingdom
Prior art keywords
antibiotic resistance
reducing antibiotic
resistance emergence
emergence
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2102556.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Destiny Pharma Ltd
Original Assignee
Destiny Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Destiny Pharma Ltd filed Critical Destiny Pharma Ltd
Priority to GBGB2102556.4A priority Critical patent/GB202102556D0/en
Publication of GB202102556D0 publication Critical patent/GB202102556D0/en
Priority to PCT/GB2022/050477 priority patent/WO2022180380A1/en
Priority to CN202280015623.9A priority patent/CN116916911A/en
Priority to TW111106601A priority patent/TW202245752A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
GBGB2102556.4A 2021-02-23 2021-02-23 Method for reducing antibiotic resistance emergence Ceased GB202102556D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2102556.4A GB202102556D0 (en) 2021-02-23 2021-02-23 Method for reducing antibiotic resistance emergence
PCT/GB2022/050477 WO2022180380A1 (en) 2021-02-23 2022-02-22 Combination of mupirocin with porphyrin-based photosensitizers for reducing antibiotic resistance emergence
CN202280015623.9A CN116916911A (en) 2021-02-23 2022-02-22 Combination of mupirocin with porphyrin-based photosensitizers for reducing the appearance of antibiotic resistance
TW111106601A TW202245752A (en) 2021-02-23 2022-02-23 Method for reducing antibiotic resistance emergence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2102556.4A GB202102556D0 (en) 2021-02-23 2021-02-23 Method for reducing antibiotic resistance emergence

Publications (1)

Publication Number Publication Date
GB202102556D0 true GB202102556D0 (en) 2021-04-07

Family

ID=75339323

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2102556.4A Ceased GB202102556D0 (en) 2021-02-23 2021-02-23 Method for reducing antibiotic resistance emergence

Country Status (4)

Country Link
CN (1) CN116916911A (en)
GB (1) GB202102556D0 (en)
TW (1) TW202245752A (en)
WO (1) WO2022180380A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
GB2415373A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Porphyrins for sonodynamic therapy
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB0526474D0 (en) 2005-12-24 2006-02-08 Destiny Pharma Ltd Novel process
BRPI0920042B1 (en) 2008-10-24 2021-06-29 Destiny Pharma Limited USE OF A COMPOUND IN THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF A BACTERIAL BIOFILM INFECTION

Also Published As

Publication number Publication date
WO2022180380A1 (en) 2022-09-01
TW202245752A (en) 2022-12-01
CN116916911A (en) 2023-10-20

Similar Documents

Publication Publication Date Title
GB202100827D0 (en) Method
GB202006815D0 (en) Method
GB202004944D0 (en) Method
GB202004863D0 (en) Method
GB202102556D0 (en) Method for reducing antibiotic resistance emergence
GB202014709D0 (en) Method
GB202014432D0 (en) Method
GB202011823D0 (en) Method
GB202010922D0 (en) Method
GB202010046D0 (en) Method
GB202007044D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
EP4093883A4 (en) Bacterial quantification method
EP4110831C0 (en) Degradative method
GB202100365D0 (en) Method
GB202020183D0 (en) Method
GB202020180D0 (en) Method
GB202018514D0 (en) Method
GB202018262D0 (en) Method
GB202018125D0 (en) Method
GB202017861D0 (en) Method
GB202017725D0 (en) Method
GB202016334D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)